Friday, July 20, 2018
Company News: Page (1) of 1 - 07/03/18 Email this story to a friend. email article Print this page (Article printing at page facebook
Combatting the National Opioid Epidemic: MEDNAX Launches Second Installment of Continuing Education Webinar Series Available to All Clinical Professionals Beginning July 10

(July 03, 2018)

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--$MD #MEDNAX--MEDNAX, Inc. (NYSE:MD), the national health solutions partner specializing in anesthesiology, neonatology, maternal-fetal medicine, other pediatric services, radiology and management services, will launch the second installment of its continuing education webinar series beginning July 10 as part of its ongoing commitment to help address the nation’s opioid crisis. Offered through the MEDNAX Center for Research, Education, Quality and Safety (CREQS), the courses are complimentary and open to all clinical professionals within and outside of the Company.

CREQS empowers health care providers to Take great care of the patient, every day and in every way™. As part of MEDNAX’s dedication to improving patient care through evidence-based medicine, the Company engages in various clinical research, education, continuous quality improvement and safety initiatives. These efforts contribute to better patient outcomes and reduced long-term health system costs not only for patients and hospital partners but for all patients and providers across MEDNAX’s specialty areas.

The webinars will optimize multidisciplinary fields to provide broad information access for participating clinicians, all featuring a live Q&A:

“As the opioid crisis continues to be a nationwide public health emergency, providing specialized continuing clinical education is one of our many important ongoing initiatives,” said Dr. Jorge Del Toro, Chief Medical Officer, Women’s & Children’s Services, MEDNAX. “Physician education is a key component to battling this epidemic, and we are committed to doing our part.”

“Our team of clinical experts have treated patients on the continuum of care for nearly 40 years, giving us the valuable experience needed to offer this crucial multidisciplinary training,” said Dr. Michael Murphy, Chief Medical Officer, Anesthesiology and Adult Critical Care Services, MEDNAX. “Our goal is to give all of our peers in the medical community the tools needed to treat patients effectively and safely.”

For more information, please visit CREQS online or email [email protected].


MEDNAX, Inc. is a national health solutions partner based in Sunrise, Fla. comprised of the nation's leading providers of physician services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives, clinical research and telemedicine to enhance patient outcomes and provide high-quality, cost-effective care. The Company was founded in 1979, and today, through its affiliated professional corporations, MEDNAX provides services through a network of approximately 4,100 physicians in all 50 states and Puerto Rico. In addition to its national physician network, MEDNAX provides services to healthcare facilities and physicians in over 40 states through two complementary businesses, consisting of a revenue cycle management company and a consulting services company. Additional information is available at


Jennifer Gutierrez, 954.384.0175 ext. 5684
Corporate Communications Specialist
[email protected]

Page: 1

Related Keywords:
Related Sites: DMN Newswire , ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   IBN - IT Weekly Newsletter ,   DMN Newswire Newsletter

  • Healthcare IT Market 2018 - 2023 with SWOT Analysis regarding upcoming Changes and Technology Adaptations in Global Healthcare Sector
  • Vision Care Product Market To Witness Enhanced Growth Owing To Rising Occurrence Of Eye Disorders Till 2021 | Million Insights
  • Global Prosthetic Heart Valve Market Reaching at a CAGR of +12.70% by Geography, Deployment Model, Component, and Key players are Boston Scientific Cardiology, CryoLife, Inc., Abbott
  • Trauma Fixation Global Market to Register Steady Expansion During 2018-2025
  • Global Surgical Apparel Market Will Reach USD 2,966.58 million by 2024: Zion Market Research

  • Mesothelioma is a Deadly Cancer and it’s Completely Preventable
  • HedgePath Pharmaceuticals Granted Exclusive Option to License UCONN's Patented Chemical Analogues of Itraconazole
  • Alligator Bioscience Submits Application to Start Clinical Phase I Study in Cancer Patients with ATOR-1015, a Unique CTLA-4 and OX40 Binding Antibody
  • Yisheng Biopharma Announces Opening of New Business Divisions in Cambodia, Expanding Presence within Southeast Asia
  • Omega-3 Market to Reach US$ 16.37 Bn by 2023, Globally -

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines